The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

ASCO & The Conquer Cancer Foundation announce merit awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Conquer Cancer Foundation of the American Society of Clinical Oncology announced the recipients of its 2019 ASCO Annual Meeting Merit Awards. These awards support oncology trainees who are first authors on abstracts selected for presentation at the ASCO annual meeting.

This year, Conquer Cancer recognized 125 recipients with Merit Awards at the 2019 ASCO Annual Meeting, having already awarded 33 symposia-specific Merit Awards in 2019. These oncology professionals are recognized for their respective field and research advancements within the cancer care community.

The complete list of 2019 ASCO Annual Meeting Merit Award is posted here.

Special Merit Awards are presented each year to trainees and junior faculty who have the top-ranking abstracts for the ASCO Annual Meeting. The ASCO Scientific Program Committee will present five additional recipients with Special Merit Awards in their respective abstract categories:

  • Dai Chihara, NCI at NIH

    • Receives the Bradley Stuart Beller Endowed Merit Award for the highest ranking abstract overall.

    • Supported by Friends and Family of Dr. and Mrs. Ronald Beller.

  • Sarah Abou Alaiwi, Dana-Farber Cancer Institute

    • Receives the Allen S. Lichter, MD, Endowed Merit Award for the second highest ranking abstract overall.

  • Po-Ju Lin, University of Rochester Medical Center

    • Receives the Pain and Symptom Management Special Merit Award for the highest ranked abstract in pain and symptom management research.

  • Adriana Fonseca, The Hospital for Sick Children

    • Receives the Brigid Leventhal Special Merit Award for the top-ranking abstract in pediatric oncology.

    • Supported by The Berry Family.

  • Sumit Gupta, The Hospital for Sick Children

    • Receives the James B. Nachman Endowed ASCO Junior Faculty Award in Pediatric Oncology for the highest scoring abstract in pediatric oncology.

    • Supported by Friends and Family of Dr. James B. Nachman.

Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

By Claire Marie Porter and Sara Willa Ernst
Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
By Mikkael A. Sekeres
Sponsored

Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration

When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.
By The American Society of Clinical Oncology
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account